Esperion Therapeutics Inc (ESPR)
Working Capital Ratio
34.40%
Quarterly · Period ending:

ESPR Working Capital Ratio
Latest reported34.40%period ending
Latest reported34.40%period ending
ESPR Quarterly Working Capital Ratio (81.43% → 34.40%)
Quarterly working capital ratio
High-resolution chart · PNG
ESPR working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 34.3983% | |
| -28.5387% | |
| 0.3931% | |
| 12.6191% | |
| 14.7555% | |
| 26.6898% | |
| 45.1053% | |
| 48.1864% | |
| 53.9039% | |
| 21.7891% | |
| 36.3837% | |
| 53.2558% | |
| 61.5994% | |
| 62.2633% | |
| 57.3608% | |
| 55.9915% | |
| 61.7565% | |
| 66.9881% | |
| 40.9237% | |
| 68.6477% | |
| 62.6986% | |
| 71.287% | |
| 66.4847% | |
| 71.89% | |
| 55.2076% | |
| 67.9114% | |
| 76.7587% | |
| 81.8645% | |
| 74.0843% | |
| 54.5824% | |
| 72.3582% | |
| 72.9886% | |
| 70.1754% | |
| 61.4681% | |
| 54.8802% | |
| 75.5514% | |
| 77.539% | |
| 80.7412% | |
| 77.8294% | |
| 72.6046% | |
| 66.7961% | |
| 70.6322% | |
| 69.1975% | |
| 69.213% | |
| 83.9082% | |
| 70.6524% | |
| 80.8657% | |
| 80.6255% | |
| 78.4515% | |
| 72.0582% | |
| 80.4163% | |
| 65.2432% | |
| 88.0395% | |
| -137.2304% | |
| 88.0217% | |
| 68.3328% | |
| 75.646% | |
| 78.4524% | |
| 80.0427% | |
| 81.2441% | |
| 81.6464% | |
| 82.8772% | |
| 83.5717% | |
| 80.1508% | |
| 81.2503% | |
| 82.4133% | |
| 83.1004% | |
| 68.4546% | |
| 81.4305% |